www.fool.com Β·
1 wall street analyst says tilray stock could jump

Topic context
This topic has been covered 249707 times in the last 30 days across our monitored publishers.
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedThe article is an analyst upgrade for Tilray Brands, a cannabis and beverage company. The commercial mechanism is weak: it is a stock rating change with no concrete operational catalyst, supply/demand shift, or regulatory change. The upgrade cites revenue growth in international cannabis and beverages, but the company has missed estimates and faces industry headwinds. No direct impact on commodity prices, supply chains, or margins is identified. The primary sector is consumer discretionary (cannabis/beverage), but the mechanism is too weak to assert strong sector relevance.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources β not direct quotes from the publisher.
- Tilray stock is over 60% below its 52-week high and down >20% YTD.
- Roth Capital analyst Bill Kirk upgraded Tilray from neutral to buy with a $10 price target (40%+ upside).
- International cannabis net revenue rose 70% YoY to $24.1 million.
- Beverage revenue increased 22% YoY to $42.6 million.
- Tilray has missed consensus revenue estimates and faces ongoing industry challenges.
Related stories
finance.yahoo.com
Manulife Financial Q1 Earnings Call
finance.yahoo.com
Nextera Dominion Energy Merger Create
finance.yahoo.com
Ascend Wellness Q1 Earnings Call
finance.yahoo.com
Eurodry Edry Q1 2026 Earnings

moneycontrol.com